Serum IgM and IgG antibody response six months post-COVID-19 vaccination
10.19428/j.cnki.sjpm.2022.21598
- VernacularTitle:新型冠状病毒疫苗接种6个月后血清IgM和IgG抗体水平的分析
- Author:
Lin WANG
1
;
Yingrong DU
1
;
Zhiqiang MA
1
;
Jie LI
1
;
Shuqiong ZHANG
1
;
Xiaoqing TANG
1
;
Chunyan QU
1
;
Yaru DUAN
1
;
Caixin LI
1
Author Information
1. The Third People’s Hospital of Kunming， Kunming， Yunnan 650301， China
- Publication Type:Journal Article
- Keywords:
SARS-CoV-2;
vaccine;
serum;
IgM antibody;
IgG antibody
- From:
Shanghai Journal of Preventive Medicine
2022;34(2):126-129
- CountryChina
- Language:Chinese
-
Abstract:
Objective To determine the serum IgM and IgG antibody levels post-COVID-19 vaccination， and provide scientific evidence for COVID-19 antibody response after vaccination. Methods A total of 980 healthy persons were included in Kunming Third People’s Hospital from July through August， 2021， which had been vaccinated with COVID-19 vaccines and then tested for anti-SARS-CoV-2 IgM and IgG antibodies. Results After the COVID-19 vaccination， 469 persons （positive rate， 47.86%） were positive for anti-IgG antibody. Of them， 75 were males with （positive rate， 39.06%）， and the average IgG level was 0.618 （0.180， 2.526） AU·mL-1［M（Q1，Q3）］； 394 were females （50.00%）， and the IgG level was 0.999 （0.305， 3.334） AU·mL-1. In addition， 53 persons （5.41%） were anti-IgM antibody positive. Of them， 14 were males （positive rate， 7.29%）， and the average IgM level was 0.057 （0.026， 0.195） AU·mL-1； 39 were females （4.95%）， and the IgM level was 0.047 （0.027， 0.110） AU·mL-1. The positive rate of anti-IgG antibody was highest in those aged ≤30 years， which was 51.02% in male （n=25） and 55.88% in female （n=133）. The anti-IgG response differed significantly by gender （χ2=7.401， D=0.135 1， P<0.05）， whereas the anti-IgM response was not significantly different （χ2=1.656， P>0.05）. Among the age groups， anti-IgG antibody level was higher in those aged ≤30 and 51-70 years， with 158 （55.05%） and 122 （52.36%） persons， respectively； the average antibody level was 1.209 （0.426， 4.386） AU·mL-1 and 1.074 （0.191， 7.670） AU·mL-1， respectively. The differences in the positive rates of IgG and IgM antibodies and the levels of IgG antibodies among different age groups were statistically significant （P<0.05）. Using Kruskal-Wallis test and Spearman correlation analysis， it showed a high correlation between the IgG and IgM antibodies （r=0.836 4， H=64.82， 20.09， P<0.05）. Conclusion The Anti-SARS-CoV-2 IgG antibody remains high six months post-COVID-19 vaccination， while anti-IgM antibody is low. The IgM and IgG response are higher in the young and elderly. The response differs by gender and age， demonstrating a correlation.
